C16H20N6O
Neat
312.37
Tofacitinib; 477600-75-2; Tasocitinib; 3-((3R, 4R)-4-methyl-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; CP-690550; CP 690550; Cp-690 free base; tofacitinibum; CP690550; 87LA6FU830; CP-690550 FREE BASE; CP-690, 550 FREE BASE; 3-{(3R, 4R)-4-methyl-3-[methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile; CP690, 550; CP-690-550; CHEBI:71200; DTXSID90197271; CP-690; 3-((3R, 4R)-4-Methyl-3-(methyl(7H-pyrrolo(2, 3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; 3-[(3R, 4R)-4-methyl-3-[methyl({7H-pyrrolo[2 and 3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
3-[(3R, 4R)-4-methyl-3-[methyl(7H-pyrrolo[2 and 3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1